ISSN 0975-3583

Journal of Cardiovascular Disease Research

    Ventilator-associated pneumonia risk factors, clinical and biochemical characteristics and predictive variables

    Dr. Gorakati Mukunda Reddy, Dr. GS Vikram
    JCDR. 2022: 1149-1155


    Connected to the Ventilator Patients who develop pneumonia after 48 hours of intubation are considered to have developed pneumonia. It causes a lot of trouble and costs a lot of money because of things like hospital stays and deaths. It has been estimated that 3% of intubated patients develop VAP daily within the first five days. Material and Methods: This prospective observational study was carried out in the several Intensive Care Units at the tertiary referral center for pulmonary medicine in Tamil Nadu, Sri Sathya Sai Medical College and Hospital. Between July 2021 and June 2022, this research was conducted. Results: Since we wanted to learn the clinical and biological profile of VAP in our ICUs, we took these precautions to make sure none of the data we collected was tainted in any way. The patients in the study had a mean age of 45. The median time to develop ventilator-related pneumonia after intubation was 7 days. On average, they spent 14 days in the hospital and spent a total of 23 days there. Procalcitonin levels were only checked in 59 individuals. One patient was released from the intensive care unit (ICU) before treatment was finished at their request. Conclusion: Later-onset VAP, or Late VAP, is more likely in ventilated patients who had normal chest x-rays at the time of intubation. Acinetobacter is the most prevalent microbe, followed by Pseudomonas and Klebsiella. The prevalence of resistant species over sensitive ones did not affect the results.


    » PDF

    Volume & Issue

    Volume 13 Issue 7